Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Outline of Final Research Achievements |
I studied the mechanism underlying urinary excretion of megalin, a multiligand endocytic receptor in the proximal tubules, in diabetic kidney disease (DKD). Urinary extracellular vesicle (UEV) excretion and full-length megalin (C-megalin) content in UEVs or in their exosomal fraction increased along with the progression of the albuminuric stages in patients with type 2 diabetes mellitus (T2DM). C-megalin excretion from cultured immortalized rat proximal tubule cells via extracellular vesicles was increased via lysosomal dysfunction in association with megalin-mediated cellular uptake of advanced glycation endproducts, which is significantly blocked by an exosome-specific inhibitor, GW4869. In a high-fat diet-induced, megalin-mediated DKD model in mice, urinary C-megalin excretion also increased via UEVs. Collectively, exocytosis-mediated urinary C-megalin excretion is linked with the megalin-mediated mechanism underlying the development and progression of DKD in T2DM.
|